- Home
- LVO vs XLO Comparison
LVO vs XLO Comparison
Compare LVO & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LVO | XLO |
|---|---|---|
| Founded | 2009 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.2M | 39.4M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LVO | XLO |
|---|---|---|
| Price | $4.98 | $0.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $13.00 | $2.00 |
| AVG Volume (30 Days) | 72.9K | ★ 417.7K |
| Earning Date | 05-12-2026 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.57 | 60.79 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $114,405,000.00 | $6,344,000.00 |
| Revenue This Year | N/A | $626.78 |
| Revenue Next Year | $28.61 | $79.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.43 | $0.50 |
| 52 Week High | $6.04 | $1.18 |
Technical Indicators
Market Signals| Indicator | LVO | XLO |
|---|---|---|
| Relative Strength Index (RSI) | 49.81 | 49.10 |
| Support Level | $3.95 | $0.51 |
| Resistance Level | $5.55 | $0.61 |
| Average True Range (ATR) | 0.45 | 0.04 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 29.36 | 65.60 |
Price Performance
Historical ComparisonAbout LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.